These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 32428809)

  • 1. Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role.
    Magro G
    Med Hypotheses; 2020 Sep; 142():109829. PubMed ID: 32428809
    [No Abstract]   [Full Text] [Related]  

  • 2. Focus on coronavirus disease 2019 associated coagulopathy.
    Yang XH; Li RR; Sun RH; Liu J; Chen DC
    Chin Med J (Engl); 2020 Sep; 133(18):2239-2241. PubMed ID: 32858589
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 and Hypercoagulability.
    Sholzberg M
    Clin Adv Hematol Oncol; 2020 Jul; 18(7):386-389. PubMed ID: 32903249
    [No Abstract]   [Full Text] [Related]  

  • 4. [Coagulopathy and COVID-19. Recommendations for a changing reality].
    Riveros D; Maymó D; Laviano J; Fornillo FF; Fernández J; Benzadon R; Solimano J; Cacchione R; Riera L; Duarte P; Cazap N; Gotta D; García Altuve J; Valentini R; Dupont J
    Medicina (B Aires); 2020; 80(5):505-511. PubMed ID: 33048795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 coagulopathy: an evolving story.
    The Lancet Haematology
    Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 coagulopathy vs disseminated intravascular coagulation.
    Levi M
    Blood Adv; 2020 Jun; 4(12):2850. PubMed ID: 32574369
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 and SIC (!).
    Nevzorov I; Tulamo R; Albäck A; Lassila R
    J Vasc Surg; 2020 Sep; 72(3):1148-1150. PubMed ID: 32497749
    [No Abstract]   [Full Text] [Related]  

  • 8. Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients.
    Ahmed SI; Khan S
    Curr Probl Cardiol; 2020 Sep; 45(9):100648. PubMed ID: 32703535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation abnormalities and thrombosis in patients with COVID-19.
    Levi M; Thachil J; Iba T; Levy JH
    Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672
    [No Abstract]   [Full Text] [Related]  

  • 10. Coagulopathy in COVID-19: Focus on vascular thrombotic events.
    Shi W; Lv J; Lin L
    J Mol Cell Cardiol; 2020 Sep; 146():32-40. PubMed ID: 32681845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostasis profile in COVID-19 infection.
    Duarte FB; Machado RPG; Lemes RPG; Duarte IA; Duarte BA; Machado CMG; Duarte JVA; Rocha SGMD; Moura ATG; Holanda RARR
    Rev Assoc Med Bras (1992); 2020 May; 66(5):571-572. PubMed ID: 32638971
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 coagulopathy: An in-depth analysis of the coagulation system.
    Martín-Rojas RM; Pérez-Rus G; Delgado-Pinos VE; Domingo-González A; Regalado-Artamendi I; Alba-Urdiales N; Demelo-Rodríguez P; Monsalvo S; Rodríguez-Macías G; Ballesteros M; Osorio-Prendes S; Díez-Martín JL; Pascual Izquierdo C
    Eur J Haematol; 2020 Dec; 105(6):741-750. PubMed ID: 32749010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research progress of coagulation dysfunction in coronavirus disease 2019].
    Zhong S; Wu F; Peng N; Xie Q; Song J; Li W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1135-1138. PubMed ID: 33081906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2: What is known and what there is to know-Focus on coagulation and lipids.
    Carbone F; Montecucco F; Twickler M
    Eur J Clin Invest; 2020 Jul; 50(7):e13311. PubMed ID: 32511751
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).
    Marietta M; Ageno W; Artoni A; De Candia E; Gresele P; Marchetti M; Marcucci R; Tripodi A
    Blood Transfus; 2020 May; 18(3):167-169. PubMed ID: 32281926
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count.
    Amgalan A; Othman M
    Platelets; 2020 Aug; 31(6):740-745. PubMed ID: 32456506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.
    Pooni RS
    Clin Med (Lond); 2020 Jul; 20(4):e59. PubMed ID: 32675158
    [No Abstract]   [Full Text] [Related]  

  • 18. Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy-Either, Neither, or Both.
    Levi M; Thachil J
    Semin Thromb Hemost; 2020 Oct; 46(7):781-784. PubMed ID: 32512589
    [No Abstract]   [Full Text] [Related]  

  • 19. ISTH interim guidance on recognition and management of coagulopathy in COVID-19.
    Thachil J; Tang N; Gando S; Falanga A; Cattaneo M; Levi M; Clark C; Iba T
    J Thromb Haemost; 2020 May; 18(5):1023-1026. PubMed ID: 32338827
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetes and severity of COVID-19: What is the link?
    Pitocco D; Viti L; Tartaglione L; Di Leo M; Rizzo GE; Manto A; Rizzi A; Caputo S; Pontecorvi A
    Med Hypotheses; 2020 Oct; 143():109923. PubMed ID: 32485315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.